Sarepta Therapeutics Inc.
SRPT:NASDAQ
Sarepta Therapeutics is a biopharmaceutical company developing RNA-targeted therapeutics that addres serious and life-threatening diseases including Duchenne muscular dystrophy and infectious diseases such as influenza, and the Ebola virus.
Streetwise Company Fact Sheet2024/4/15 23:24:27
(SRPT:NASDAQ)
Newsletter coverage
| — |
Streetwise Reports Articles
| 11/07/2023 - View Article |
| 11/01/2023 - View Article |
| 08/05/2022 - View Article |
| 07/09/2022 - View Article |
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
